KMC Speciality Hospitals (India) Ltd

Q1 FY27Healthcare Services

KMC Speciality Hospitals (India) Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.

Price₹156

Market cap₹2.5K Cr

P/E43.9

Updated25 Sept 2026

Read4 min read

Based on KMC Speciality Hospitals (India) Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. EBITDA for Q1 FY'27 is INR 30.3 Cr, up 76% from INR 17.3 Cr in Q1 FY'26.

From KMC Speciality Hospitals (India) Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26.
Q1 FY'27 Total Income: INR 93.6 Cr, up 39% YoY from INR 67.4 Cr in Q1 FY'26.
Q1 FY'27 EBITDA: INR 30.3 Cr, up 76% YoY from INR 17.3 Cr in Q1 FY'26.
Q1 FY'27 PAT: INR 16.6 Cr, up 120% YoY from INR 7.5 Cr in Q1 FY'26.
Occupied Bed Days: 25,732 in Q1 FY'27, 25% increase YoY from 20,642 in Q1 FY'26.
In-Patient Volumes: 5,168 in Q1 FY'27, 25% increase YoY from 4,149 in Q1 FY'26.

2 more points management made on revenue & sales performance

Profitability & Margins

EBITDA for Q1 FY'27 is INR 30.3 Cr, up 76% from INR 17.3 Cr in Q1 FY'26.
EBITDA margin for Q1 FY'27 is 32.4%, compared to 25.6% in Q1 FY'26.
Profit After Tax (PAT) for Q1 FY'27 is INR 16.6 Cr, up 120% from INR 7.5 Cr in Q1 FY'26.
PAT margin for Q1 FY'27 is 17.7%, compared to 11.2% in Q1 FY'26.

2 more points management made on profitability & margins

See what KMC Speciality Hospitals (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

New facility "Maa Kauvery" commenced operations from January 2024 (Page 29).
Loan availed specifically for "Maa Kauvery" facility; total borrowings for this new facility were INR 68.3 Cr as of 30th June 2026 (Page 21).
Capital Work In Progress (CWIP) reported as INR 1.57 Cr as of June 2026, compared to nil in FY’26 (Page 21).
Capacity: Legacy block has 250 beds (G+6F+1B), and new block has 200 beds (G+5F+2B) (Page 7).

- Occupied beds increased to 330 with no growth in census beds, indicating full utilization of existing capacity (Page 24). - No specific capex amount is explicitly stated beyond loan size; timelines mention "Maa Kauvery" operational since Jan 2024 (Page 29). Overall, the key project is the new "Maa Kauvery" facility operational since early 2024, supported by borrowings and some ongoing minor CWIP.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Total Borrowings (Term Loan + CC) at the end of 30th Jun 2026 is INR 68.3 Cr; this borrowing is specifically incurred for the new facility "Maa Kauvery" (Page 21).
Borrowings have changed over years, e.g., borrowings were INR 61.43 Cr in FY'26 and 58.70 Cr in the period ending Jun'26 (FY'27 Q1) (Pages 31, 21).
Net Debt is negative because cash and cash equivalents exceed borrowings; therefore, Net Debt to EBITDA ratio is considered zero (Page 23).

2 more points management made on fundraising & capital structure

See what KMC Speciality Hospitals (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation for KMC Speciality Hospitals (India) Ltd does not report any information on order book, order inflow, or pending orders. - There is no mention or data related to order book size or value. - No details on new order inflows during the reported periods. - No information on pending or backlog orders. The presentation focuses primarily on financial performance, operational metrics, cash flows, and hospital-specific data such as bed occupancy, patient volumes, revenues, and profitability.

KMC Speciality Hospitals (India) Ltd — Quarterly revenue & net profit

Revenue Net profit

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹82 Cr, net profit ₹14 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What KMC Speciality Hospitals (India) Ltd's management said in earlier quarters

Q4 FY26 earnings call analysis →

Others in Healthcare Services this season

3B Blackbio DX Ltd (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Thyrocare Technologies Ltd (Q1 FY27)
Pathology business grew ~27%; franchisee business grew ~23-27% YoY, reflecting strong volume growth. Key concall takeaways from Thyrocare Technologies Ltd's Q1…
Krsnaa Diagnost. (Q1 FY27)
. Key concall takeaways from Krsnaa Diagnost.'s Q1 FY27 earnings call — and how it ranks against sector peers.
Artemis Medicare (Q1 FY27)
Potential to reach INR 2,000 crores topline from Gurgaon alone within 3-5 years. Key concall takeaways from Artemis Medicare's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were KMC Speciality Hospitals (India) Ltd Q1 FY27 results?

Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. EBITDA for Q1 FY'27 is INR 30.3 Cr, up 76% from INR 17.3 Cr in Q1 FY'26.

What is KMC Speciality Hospitals (India) Ltd share price analysis?

KMC Speciality Hospitals (India) Ltd currently shows a neutral. The stock trades at a P/E of 43.9 with a market cap of ₹2,451 Cr. Investors should review the full earnings analysis for detailed insights.

Is KMC Speciality Hospitals (India) Ltd planning capital expenditure?

New facility "Maa Kauvery" commenced operations from January 2024 (Page 29).

Keep KMC Speciality Hospitals (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.